| 000 | 01139 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514024304.0 | ||
| 264 | 0 | _c20020516 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood.v99.5.1503a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFefer, Alexander | |
| 245 | 0 | 0 |
_a"Special delivery" to cancer cells. _h[electronic resource] |
| 260 |
_bBlood _cMar 2002 |
||
| 300 |
_a1503-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aExtracellular Matrix _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _ximmunology |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 773 | 0 |
_tBlood _gvol. 99 _gno. 5 _gp. 1503-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.v99.5.1503a _zAvailable from publisher's website |
| 999 |
_c11769145 _d11769145 |
||